1. Home
  2. MATH vs MCRB Comparison

MATH vs MCRB Comparison

Compare MATH & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

SELL

Current Price

$1.04

Market Cap

49.9M

Sector

Finance

ML Signal

SELL

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$1.41

Market Cap

41.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATH
MCRB
Founded
2015
2010
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.9M
41.2M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
MATH
MCRB
Price
$1.04
$1.41
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
29.1K
★ 82.3K
Earning Date
08-06-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $789,000.00
Revenue This Year
N/A
$1,648.67
Revenue Next Year
N/A
N/A
P/E Ratio
$3.10
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$1.30
52 Week High
$3.19
$29.98

Technical Indicators

Market Signals
Indicator
MATH
MCRB
Relative Strength Index (RSI) 52.88 23.16
Support Level $0.93 N/A
Resistance Level $1.13 $2.26
Average True Range (ATR) 0.09 0.23
MACD -0.00 0.01
Stochastic Oscillator 60.26 11.46

Price Performance

Historical Comparison
MATH
MCRB

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd mainly operates in the trading of proprietary digital assets and derivative contracts in Hong Kong. The Company's primary business operations center on digital asset services, offered through its subsidiaries. The Company generates income mainly from executing cryptocurrency-related transactions, including providing derivative solutions to over-the-counter (OTC) clients, issuing derivative products to OTC clients, and engaging in proprietary trading activities. The Company provides crypto derivative solutions and liquidity to its clients, facilitated through its principal trading activities, enabling seamless trading of crypto derivative solutions. The Company generates revenue from Hong Kong.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: